
BA.3.2, a new COVID-19 variant, has been detected in 23 countries including 29 US states. The variant contains numerous spike-protein mutations but shows no increased severity or sustained growth advantage over other variants. WHO classifies it as a variant under monitoring. Vaccines continue providing strong protection against severe disease. Symptoms resemble recent Omicron subvariants. Monitoring continues globally.